Physician

Pui-Sum Susan Wong, M.D.

According to 2025 Medicare claims, Pui-Sum Wong, M.D. (NPI: 1912975111) practices internal medicine in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is COLLOM & CARNEY CLINIC ASSOCIATION (NPI: 1619959244; TIN: 751151440) and primary practice location at 75503-9766. Wong is affiliated with the Prime Care Managers, LLC (ACO ID: A3280), participating under the MSSP model.

Wong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 858 traditional Medicare patients, billed 68,071 HCPCS/CPT codes, and received $1,032,098 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 23,273 prescription claims across 1,041 beneficiaries totaling $2,194,558 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 508 claims. Open Payments data shows 35 records totaling $691. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $470,306 to $1,032,098. Similarly, Part D prescription costs have moved sharply higher in recent years, from $935,998 to $2,194,558. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $39,470 to $100,910.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,394	27,282	$470,306
2016	1,658	39,032	$569,115
2017	1,798	32,800	$615,898
2018	1,552	36,756	$618,771
2019	1,494	30,717	$621,318
2020	1,414	27,806	$594,968
2021	1,189	26,592	$618,832
2022	1,067	36,816	$716,411
2023	967	56,842	$917,446
2024	858	68,071	$1,032,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	747	14,372	$935,998
2016	768	15,710	$1,008,806
2017	926	16,352	$1,029,039
2018	891	17,461	$1,130,814
2019	978	17,800	$1,284,565
2020	972	18,506	$1,433,140
2021	921	17,906	$1,397,274
2022	894	18,617	$1,609,680
2023	923	20,376	$2,172,313
2024	1,041	23,273	$2,194,558

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	271	995	$50,440
2016	234	1,027	$46,045
2017	114	706	$30,274
2018	143	810	$33,939
2019	167	803	$38,850
2020	115	626	$29,507
2021	96	604	$48,694
2022	112	531	$56,816
2023	95	663	$91,687
2024	50	508	$92,406

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	678	2,286	$88
80061	Blood test, lipids (cholesterol and triglycerides)	658	1,193	$13
80053	Blood test, comprehensive group of blood chemicals	727	1,868	$10
36415	Insertion of needle into vein for collection of blood sample	731	2,501	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	718	1,535	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	321	10,176	$352,993
Eliquis	Apixaban	327	17,174	$321,440
Ozempic	Semaglutide	174	7,050	$216,209
Xtandi	Enzalutamide	12	360	$175,425
Farxiga	Dapagliflozin Propanediol	183	9,257	$147,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	35	181	$70,877
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,150
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	72	$4,865
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	12	$1,862
A7031	Face mask interface, replacement for full face mask, each	N	N/R	14	$1,353

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$691	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pui-Sum Susan Wong, M.D.?

Tedicare shows public-source Medicare data for Pui-Sum Susan Wong, M.D. (NPI 1912975111), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pui-Sum Susan Wong, M.D. have ACO affiliation data?

Pui-Sum Susan Wong, M.D. is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280).

What billing organization is linked to Pui-Sum Susan Wong, M.D.?

Pui-Sum Susan Wong, M.D. is linked to COLLOM & CARNEY CLINIC ASSOCIATION (billing NPI 1619959244) in the available physician profile data.

Does Pui-Sum Susan Wong, M.D. have Open Payments data?

Pui-Sum Susan Wong, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.